Sign in to skip this page and read original articles directly.
Jan 25, 2014 - 03:19 GMT

The Mumbai-based Glenmark Pharmaceuticals Limited has posted a net profit of Rs 216 crore against a PAT of Rs 212 crore for the previous corresponding quarter. According to the company, net profit for the quarter is not comparable due to out-licensing income of Rs 49 crore received in Q3 FY 2012-13. For the third quarter ended Dec 31, 2013, Glenmark’s consolidated revenue was at … (continue reading)